コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 leiomyomatosis and pulmonary Langerhans cell histiocytosis.
2 Erdheim-Chester disease and Langerhans'-cell histiocytosis.
3 ster disease (ECD) is a rare, non-Langerhans histiocytosis.
4 ytic human diseases, such as Langerhans cell histiocytosis.
5 Erdheim-Chester disease and Langerhans cell histiocytosis.
6 gated in patients with malignant BRAF(V600E) histiocytosis.
7 taneous and progressive macrophage-dominated histiocytosis.
8 blastoma, some sarcomas, and Langerhans cell histiocytosis.
9 plant (UCBT) for refractory Langerhan's cell histiocytosis.
10 g pneumonia), and pulmonary Langerhans' cell histiocytosis.
11 ine staging and diagnosis of Langerhans cell histiocytosis.
12 he self-limiting, cutaneous form of human LC histiocytosis.
13 d in this respect CCH differed from human LC histiocytosis.
14 iopsy may reveal hemophagocytosis and marrow histiocytosis.
15 CSF transgenic mice developed a disseminated histiocytosis and had increased circulating IL-17 produc
17 anoma, conjunctival amyloidosis, and primary histiocytosis and in 1 case of ocular surface squamous n
18 presence of distinct kinase mutations in the histiocytosis and myeloid neoplasm resulted in discordan
19 se, characterized by short stature, familial histiocytosis and sinus histiocytosis with massive lymph
20 ed with Erdheim-Chester disease (ECD) (mixed histiocytosis) and discuss the significance of this asso
23 leiomyomatosis and pulmonary Langerhans cell histiocytosis are perhaps more frequently seen in the cl
24 e have developed a model for Langerhans cell histiocytosis comprising a CD1a-positive subcutaneous xe
25 iocytic disorders, including Langerhans cell histiocytosis, Erdheim-Chester disease, and Rosai-Dorfma
27 functional evidence of the cell of origin of histiocytosis from actual patient materials has long bee
31 r and molecular basis for the development of histiocytosis in several human syndromes associated with
32 or CD34(+) cells to drive the development of histiocytosis in xenotransplantation assays in vivo.
37 al of adults with pulmonary Langerhans'-cell histiocytosis is shorter than that in the general popula
38 observed in 57% of cases of Langerhans cell histiocytosis (LCH) and 54% of cases of Erdheim-Chester
39 RAF mutation in a child with Langerhans cell histiocytosis (LCH) and demonstrate that the encoded pro
41 he most common histiocytoses-Langerhans cell histiocytosis (LCH) and Erdheim-Chester disease (ECD)-wh
42 ved in half of patients with Langerhans cell histiocytosis (LCH) and in 50% to 100% of patients with
45 wo girls were diagnosed with Langerhans cell histiocytosis (LCH) at the age of 16 and 7 months and de
48 ling pathway is activated in Langerhans cell histiocytosis (LCH) histiocytes, but only 60% of cases c
64 sis of patients with proven Langerhans' cell histiocytosis (LCH) was undertaken with the aim of evalu
65 olvement at presentation of Langerhans' cell histiocytosis (LCH) with subsequent disease course, surv
69 on a group of patients with Langerhans cell histiocytosis (LCH), which historically has poor disease
74 eoside transporter, mutations in which cause histiocytosis-lymphadenopathy plus syndrome, a group of
75 ngerhans cell histiocytosis (so-called mixed histiocytosis [MH]), we identified an unexpected and her
78 who received transplants for Langerhans cell histiocytosis relative to other indications for transpla
79 ECD and ECD overlapping with Langerhans cell histiocytosis (so-called mixed histiocytosis [MH]), we i
80 ons) coexisting with those characteristic of histiocytosis (such as BRAFV600E and MAP2K1 mutations).
81 disease (ECD) is a rare non-Langerhans cell histiocytosis that most commonly affects adults and is d
82 Erdheim-Chester disease or Langerhans'-cell histiocytosis, the response rate was 43% (95% CI, 18 to
83 gically confirmed pulmonary Langerhans'-cell histiocytosis to ascertain their vital status and whethe
84 disease (ECD) is a rare non-Langerhans cell histiocytosis, to whose pathogenesis neoplastic and immu
85 o include neurodegeneration with bone marrow histiocytosis, visceromegaly, brown pancreas, and linkag
86 eneous, the phenotype of patients with mixed histiocytosis was closer to that of isolated ECD than to
87 the diagnosis of pulmonary Langerhans'-cell histiocytosis were analyzed with the Cox proportional-ha
88 risk factors, patients with Langerhans cell histiocytosis were at significantly increased risk for P
89 CCH is a localized form of self-limiting LC histiocytosis, which predominantly expresses an epiderma
92 rt stature, familial histiocytosis and sinus histiocytosis with massive lymphadenopathy (SHML), chara
95 ell histiocytosis (LCH), previously known as histiocytosis X, is a reactive proliferative disease of
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。